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Abstract
Background: Reduced fetal growth is associated with perinatal and later morbidity. Prenatal exposure to
environmental pollutants is linked to reduced fetal growth at birth, but the impact of concomitant exposure to
multiple pollutants is unclear. The purpose of this study was to examine interactions between early pregnancy
exposure to cigarette smoke, traffic pollution, and select perfluoroalkyl substances (PFASs) on birth weight-for-
gestational age (BW/GA).
Methods: Among 1597 Project Viva mother-infant pairs, we assessed maternal cigarette smoking by questionnaire,
traffic pollution at residential address by black carbon land use regression model, and plasma concentration of
select PFASs in early pregnancy. We calculated sex-specific BW/GA z-scores, an index of fetal growth, from national
reference data. We fit covariate-adjusted multi-pollutant linear regression models and examined interactions
between exposures, using a likelihood-ratio test to identify a best-fit model.
Results: Two hundred six (13%) mothers smoked during pregnancy. Mean [standard deviation (SD)] for black carbon
was 0.8 (0.3) μg/m3, perfluorooctane sulfonate (PFOS) was 29.1 (16.5) ng/mL, and BW/GA z-score was 0.19 (0.96). In the
best-fit model, BW/GA z-score was lower in infants of mothers exposed to greater black carbon [− 0.08 (95% CI: -0.15,
− 0.01) per interquartile range (IQR)]. BW/GA z-score (95% CI) was also lower in infants of mothers who smoked [− 0.09
(− 0.23, 0.06)] or were exposed to greater PFOS [− 0.03 (− 0.07, 0.02) per IQR], although confidence intervals crossed the
null. There were no interactions between exposures. In secondary analyses, instead of PFOS, we examined
perfluorononanoate (PFNA) [mean (SD): 0.7 (0.4) ng/mL], a PFAS more closely linked to lower BW/GA in our cohort. The
best-fit multi-pollutant model included positive two-way interactions between PFNA and both black carbon and
smoking (p-interactions = 0.03).
Conclusions: Concurrent prenatal exposures to maternal smoking, black carbon, and PFOS are additively associated
with lower fetal growth, whereas PFNA may attenuate associations of smoking and black carbon with lower fetal
growth. It is important to examine interactions between multiple exposures in relation to health outcomes, as effects
may not always be additive and may shed light on biological pathways.
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Background
Fetal growth restriction is a major public health chal-
lenge, as it occurs in 5 to 10% of pregnancies and is one
of the leading causes of neonatal mortality and morbid-
ity [1]. Smaller weight for gestational age at birth, an in-
dicator of fetal growth restriction, not only influences
early-life outcomes, but is associated with adverse car-
diometabolic health later in life [2].
Several in utero environmental exposures, many of
which are modifiable, are linked to reduced fetal growth.
For example, prenatal exposures to cigarette smoke, traffic
pollution, and perfluoroalkyl substances (PFASs) have
been associated with lower fetal growth in our greater
Boston area longitudinal birth cohort, Project Viva [3–5],
as well as in other epidemiological studies [6–10].
Cigarette smoke and traffic-related air pollution contain
particulate matter (PM), along with hydrocarbons, alde-
hydes, nitric oxides, and carbon monoxide [11]. Both ex-
posures are hypothesized to lower fetal growth primarily
as a result of placental oxidative stress and inflammation
[12, 13], which may disturb nutrient and oxygen exchange
from mother to fetus [12]. PFASs are synthetic com-
pounds used in the manufacture of a variety of consumer
and industrial products, including water- and stain-
resistant coatings for clothing, furniture, and carpets; oil-
resistant coatings for food packaging; non-stick cookware;
fire-fighting foams; and aviation hydraulic fluids. Almost
the entire U.S. population (> 95%) has detectable serum
concentrations of several PFAS [14–16]. PFASs may influ-
ence fetal growth by activating the peroxisome
proliferator-activated receptor (PPAR) [17], which may in-
hibit inflammatory gene expression [18, 19] and interfere
with lipid and glucose homeostasis [19, 20].
Although studies have reported robust associations of
each of these prenatal exposures with reduced fetal
growth, few prior studies have evaluated the potential
impact of these pollutants combined. This is important
because pregnant women are simultaneously exposed to
mixtures of environmental toxicants [21].
In the present analysis, we examine additive interac-
tions between early pregnancy exposure to cigarette
smoke, black carbon (an indicator of traffic pollution),
and select PFASs and their associations with birth
weight-for-gestational age (BW/GA) in the Project
Viva cohort. Based on our prior work in subsets of
this cohort, we expected to find that each exposure
would be independently associated with fetal growth
and further hypothesized that infants exposed to all
three would have the lowest expected fetal growth.
Methods
Study population and design
Between 1999 and 2002, we recruited pregnant women
into the Project Viva cohort during their initial prenatal
visit (median 9.9 weeks gestation) at Atrius Harvard
Vanguard Medical Associates, a multi-specialty group
practice with offices throughout eastern Massachusetts.
Exclusion criteria included multiple gestation, inability
to answer questions in English, gestational age greater
than or equal to 22 weeks at recruitment, and plans to
move from the area prior to delivery [22]. A total of
2128 women were initially included in the cohort. In the
present analysis, we excluded one participant without a
recorded birth weight, 21 without information on pre-
natal cigarette smoking, 37 without data on estimated
residential black carbon concentration, one for whom
the black carbon regression model provided an implaus-
ible data point, and 471 whose mother did not provide a
plasma sample or did not have sufficient sample for
quantification of PFASs and thus did not have a meas-
urement of maternal perfluorooctane sulfonate (PFOS)
plasma concentration. In total, we studied 1597 partici-
pants in the present analysis. Compared with those not
included (n = 531), mothers included in the present ana-
lysis were more likely to be white, but other characteris-
tics were similar (Additional file 1: Table S1). We
obtained written informed consent from all participants,
and the study was approved by Institutional Review
Boards of participating institutions. The involvement of
the Centers for Disease Control and Prevention (CDC)
laboratory did not constitute engagement in human sub-
ject research.
Selection and measurement of early pregnancy
environmental exposures
We collected information on maternal cigarette smoking
during pregnancy and categorized participants into three
groups: 1) prenatal smokers, 2) former smokers, and 3)
never smokers. At the first in-person study visit, we
asked expectant mothers whether they had ever smoked,
and those who smoked less than 100 cigarettes in their
lifetime were classified as “never smokers.” We asked
smokers whether they had smoked in the three months
before learning of their pregnancy, and classified women
who quit at least three months prior to pregnancy as
“former smokers.” We designated those who smoked
during the three months before learning of their preg-
nancy (i.e., likely smoked in very early pregnancy) or re-
ported smoking on the first or second trimester
questionnaire or delivery interview as “prenatal
smokers.” The majority (65%) of prenatal smokers quit
during the first trimester, and thus were primarily early
pregnancy smokers. Therefore, in secondary analyses, we
also considered the subset of prenatal smokers who con-
tinued smoking beyond the first trimester and termed
this group “continued smokers.”
We estimated prenatal exposure to several types of
traffic pollution in Project Viva [black carbon, PM2.5
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(PM ≤ 2.5 μm in aerodynamic diameter), neighborhood
traffic density, home roadway proximity] [3]. In the
present study, we evaluated prenatal exposure to black
carbon because this measure of the black particles pri-
marily emitted by traffic has been more strongly associ-
ated with health risks such as mortality and childhood
asthma, as compared to other traffic-related pollution
indicators like PM [23]. In addition, in Project Viva,
black carbon was more strongly associated with low fetal
growth than other markers of traffic pollution [3]. We
estimated daily ambient black carbon exposure at the
address each participant provided at the time of enroll-
ment (median 10 weeks gestation). We used a validated
spatiotemporal regression model, which included mea-
sures of land use, GIS location, daily meteorological fac-
tors, day of week and season, and interaction terms of
land use measures and meteorological factors as predic-
tors [24, 25]. An “out-of-sample” cross-validation
showed a correlation of 0.73 between predicted and
monitor-observed daily black carbon concentration [25].
We analyzed first trimester black carbon [average daily
exposures from date of the last menstrual period (LPM)
to the 93rd day after LPM] for consistency in timing
with the other early pregnancy exposures in this
analysis.
We also measured maternal plasma concentrations of
several PFASs [PFOS, perfluorooctanoate (PFOA), per-
fluorohexane sulfonate (PFHxS), perfluorononanoate
(PFNA), 2-(N-ethyl-perfluorooctane sulfonamido) acet-
ate, 2-(N-methyl-perfluorooctane sulfonamido) acetate,
perfluorodecanoate, and perfluorooctane sulfonamide] in
early pregnancy in Project Viva [26]. We evaluated PFOS
in our primary analysis because as compared to other
measured PFASs, mothers in Project Viva had the high-
est average concentration of PFOS plasma concentra-
tions. Likewise, PFOS has consistently been the PFAS
with the highest mean serum concentrations observed in
the U.S. general population since these chemicals were
in peak production and detected in the National Health
and Nutrition Examination Survey’s participants in
1999–2000 [15, 27]. In an a priori secondary analysis, we
examined PFNA because we have previously observed
the strongest inverse association between PFNA and
fetal growth as compared to other PFASs in our cohort
[4]. As compared to PFOS, PFNA has a narrower range
of concentrations (i.e., smaller IQR and lower mean con-
centration), but the coefficients of variation are relatively
similar (i.e., 56.9 for PFOS and 55.1 for PFNA). Al-
though PFOA is one of the most common studied PFAS,
we found null associations between maternal PFOA
plasma concentration and BW/GA in Project Viva and
thus did not evaluate PFOA in the present analysis. We
collected maternal plasma samples during the first pre-
natal visit, and samples were shipped to the CDC
(Atlanta, GA) for analysis, as previously described [26].
Briefly, staff at CDC quantified PFAS concentration in
maternal plasma using on-line solid-phase extraction
coupled to isotope dilution high performance liquid
chromatography mass spectrometry [28]. The limit of
detection (LOD) was 0.2 ng/mL for PFOS and 0.1 ng/
mL for PFNA; we replaced values below the LOD with
the LOD/√2. Two (0.1%) women had PFOS plasma con-
centrations below the LOD and 22 (1.4%) women had
PFNA plasma concentrations below the LOD.
Measurement of outcome
To compute BW/GA z-score, we abstracted birth weight
(in grams) and date of delivery from the hospital medical
record. We obtained infant sex from delivery interview.
We calculated length of gestation (in days) by subtract-
ing the date of the LMP from the date of delivery, except
in cases in which the length of gestation based on the
second trimester ultrasound was more than 10 days dif-
ferent from that by the LMP. In these cases, we used the
ultrasound result. Using these data, we calculated sex-
specific BW/GA z-score based on U.S. national reference
data [29].
Measurement of covariates
We collected information on maternal age, education,
race/ethnicity, parity, and household income using ques-
tionnaires at study enrollment. We calculated pre-
pregnancy body mass index (BMI) from self-reported
weight and height. As there is potential for the relation-
ship between PFAS concentrations and fetal growth to
be confounded by pregnancy physiology [30], we
assessed creatinine in the same maternal plasma sample
used for PFAS quantification to calculate glomerular fil-
tration rate (GFR) and measured plasma albumin to as-
sess plasma expansion, as described previously [26].
Statistical analyses
We first fit unadjusted, followed by covariate-adjusted,
linear regression models to examine the association of
each prenatal exposure (self-reported maternal prenatal
smoking, residential black carbon levels during the first
trimester, and PFOS plasma concentration during early
pregnancy) individually with BW/GA z-score. Next, we
fit a covariate-adjusted additive model that included all
three exposures simultaneously. For smoking status, we
combined the never and former smoker categories be-
cause characteristics of these women were similar and
combining the two categories did not appreciably change
results. To ease interpretability and comparison, we
present both first trimester black carbon and prenatal
PFOS plasma concentration associations per interquar-
tile range (IQR). We adjusted for covariates potentially
associated with the three prenatal environmental
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exposures [3, 26, 31] and/or fetal growth [32]. These co-
variates included maternal age at enrollment (continu-
ous), maternal pre-pregnancy BMI (continuous), race/
ethnicity (white, black, Hispanic, Asian, or other), educa-
tion (with or without a college degree), parity (nullipar-
ous or multiparous), season of birth (continuous sine
and cosine of date), and date of birth (continuous). In-
clusion of household income, maternal GFR, plasma al-
bumin, and week of gestation did not considerably
change effect estimates (> 10%) and were not significant
in adjusted models, and thus we did not include these
covariates in final models. We did not adjust for gesta-
tional glucose tolerance status or gestational weight gain
because these may be on the causal pathway between
early pregnancy exposures and fetal growth and there-
fore may introduce collider bias [33]. Ninety-nine per-
cent of participants (n = 1577) had complete covariate
information for the multivariate regression models.
Next, we evaluated interactions between the three
early pregnancy environmental exposures in the adjusted
model. Using a sequential model building approach, we
fit covariate-adjusted multi-pollutant models to examine
all possible two-way interactions between pollutants
(smoking*black carbon, smoking*PFOS, and black car-
bon*PFOS). Using a likelihood ratio test, we calculated a
chi-square p-value to compare each two-way interaction
model separately to the main effects additive model. If
the likelihood ratio test was significant (p < 0.05), indi-
cating that the more complex model was a better fit, we
used this model as the new likelihood ratio test reference
as we continued testing other models with one or mul-
tiple two-way interactions, and eventually compared it
to a final model with all two-way interactions and a
three-way interaction (smoking*black carbon*PFOS). We
thus identified a final best-fit model and present individ-
ual and interaction effect estimates.
Although dichotomizing exposures and outcomes can
improve interpretability of interaction effect estimates
[34], we opted to represent the black carbon and PFAS
exposures and the outcome (BW/GA z-score) as con-
tinuous variables to maximize power. Then, to improve
interpretability, we used the best-fit model to predict the
BW/GA z-score of an infant born to a “typical” Project
Viva mother [based on mean age (31.8 years) and pre-
pregnancy BMI (25.0 kg/m2) and modal education (col-
lege graduate), race/ethnicity (white), and parity (multip-
arous) woman] according to select levels of exposure to
the three environmental toxicants in early pregnancy.
We present extreme high and low exposure scenarios to
capture the full range of model-predicted birth size in
infants of exposed versus unexposed mothers, although
most mothers have more moderate exposures. We con-
sidered “high” exposure to be 1) prenatal smoking, 2)
first trimester black carbon exposure at the 90th
percentile (1.08 μg/m3), and 3) prenatal PFOS plasma
concentration at the 90th percentile (47.0 ng/mL). We
considered “low” exposure to be 1) no prenatal smoking,
2) first trimester black carbon exposure at the 10th per-
centile (0.43 μg/m3), and 3) prenatal PFOS plasma con-
centration at the 10th percentile (14.0 ng/mL). We
predicted infant BW/GA z-score for different mixture
combinations of high versus low prenatal exposures.
Next, we used birth weight percentiles for a white infant
born at term from U.S. national reference data [29] to
convert the predicted BW/GA z-scores to predicted
birth weight.
In a secondary analysis, we re-ran the model building
process but considered prenatal smokers to be the sub-
set of women who smoked throughout pregnancy [con-
tinued smokers: n (%) = 71 (35%)] with all other women
(including those who quit smoking during the first tri-
mester) as the reference group. As compared to early
pregnancy smoking, continued smoking throughout
pregnancy has been more strongly associated with low
birth size [6, 7, 35], but we considered continued
smokers in the secondary rather than primary analysis
due to limited power to detect an interaction based on
the relatively small number of continued smokers. We
also re-ran the model building process described above
considering PFNA rather than PFOS because in Project
Viva it was more strongly associated with smaller BW/
GA.
We used the gmodels package in R 3.3.2 (Vienna,
Austria) to calculate predicted BW/GA z-scores. For all
other analyses, we used SAS version 9.4 (Cary, NC).
Results
Of the 1597 mothers included in the analytic dataset,
mean (standard deviation [SD]) maternal age at the time
of enrollment was 31.8 (5.2) years. Sixty-five percent of
mothers were college graduates, 49% nulliparous, 69%
white, and 13% prenatally smoked. Mean (SD) residen-
tial black carbon level during the first trimester was 0.8
(0.3) μg/m3, prenatal PFOS plasma concentration was
29.1 (16.5) ng/mL, and BW/GA z-score was 0.19 (0.96)
(Table 1).
As compared to non-smokers, mothers who smoked
during early pregnancy were less educated, younger, had
a higher pre-pregnancy BMI, and were less likely to be
white. As compared to prenatal smokers, non-smokers
had slightly lower exposure to black carbon (mean
0.80 μg/m3 for smokers versus 0.75 μg/m3 for non-
smokers; p < 0.01), no difference in PFOS plasma con-
centrations (mean 29.6 ng/mL for smokers versus
29.0 ng/mL for non-smokers; p = 0.65), and no differ-
ence in PFNA plasma concentrations (mean 0.7 ng/mL
for smokers versus 0.8 ng/mL for non-smokers; p = 0.06)
(Table 1). Mean residential black carbon concentration
Rokoff et al. Environmental Health  (2018) 17:19 Page 4 of 11
was not correlated with PFAS plasma concentrations
[Spearman’s r = 0.02 for PFOS (p = 0.35) and PFNA (p =
0.54)].
In covariate-adjusted single-pollutant models, higher
black carbon exposure during the first trimester was
associated with a 0.08 reduction in BW/GA z-score
[95% confidence interval (CI): − 0.15, − 0.01] per IQR
increment (Table 2). Also, higher maternal PFOS
plasma concentration and prenatal smoking were as-
sociated with lower fetal growth, although confidence
intervals crossed the null [BW/GA z-score of − 0.03
(95% CI: -0.07, 0.02) per IQR increment in PFOS and
− 0.09 (95% CI: -0.24, 0.05) for infants of smokers
versus non-smokers] (Table 2).
In the covariate-adjusted multi-pollutant main effects
additive model, effect sizes and significance for all three
exposures in relation to fetal growth were similar to
those in the single-pollutant models (Table 2).
None of the two-way interaction terms were significantly
associated with fetal growth, and the likelihood ratio test
confirmed that the multi-pollutant additive model without
any interaction terms was the best-fit model (Table 2).
Additionally, the three-way interaction was not statistically
significant [0.16 (95% CI: -0.03, 0.35)] (data not shown).
Table 1 Participant characteristics overall (n = 1597) and by maternal smoking status, quartiles of first trimester residential black
carbon, and quartiles of prenatal perfluorooctane sulfonate (PFOS) plasma concentration
Prenatal Environmental Exposures
Prenatal smoking First trimester residential black carbona PFOS plasma concentrationb
Overall No Yes Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4
n = 1597 n = 1391 n = 206 n = 399 n = 399 n = 400 n = 399 n = 400 n = 396 n = 403 n = 398
Mean (SD) or % Mean (SD) or % Mean (SD) or % Mean (SD) or %
Maternal characteristics
Age at enrollment
(years)
31.8 (5.2) 32.2 (5.0) 29.2 (5.8) 32.9 (4.3) 32.2 (5.2) 31.5 (5.4) 30.7 (5.6) 32.5 (5.1) 31.8 (5) 31.6 (5.3) 31.5 (5.3)
Pre-pregnancy BMI
(kg/m2)
25.0 (5.6) 24.9 (5.4) 26.1 (6.2) 25.1 (5.5) 25.0 (5.1) 25.1 (5.8) 24.9 (5.7) 24.4 (5.3) 24.8 (5.4) 25.5 (5.8) 25.3 (5.6)
College graduate (%) 65 69 34 75 70 59 56 73 62 64 61
Nulliparous (%) 49 48 55 43 45 50 57 37 45 54 60
Race/ethnicity (%)
White 69 69 65 86 73 65 51 70 71 66 67
Black 15 16 14 7 13 18 25 12 14 18 18
Hispanic 7 6 11 4 6 7 12 9 7 7 6
Asian 5 5 4 3 6 4 7 5 3 5 6
Other 4 4 6 1 4 7 5 4 5 4 3
Maternal prenatal exposures
Prenatal smoking (%) 13 0 100 12 10 14 17 11 13 14 14
First trimester black
carbon (μg/m3)
0.8 (0.3) 0.7 (0.3) 0.8 (0.3) 0.4 (0.1) 0.7 (0.1) 0.8 (0.0) 1.1 (0.2) 0.7 (0.2) 0.8 (0.3) 0.8 (0.3) 0.8 (0.3)
PFOS plasma
concentration (ng/mL)
29.1 (16.5) 29.0
(16.9)
29.6
(14.1)
29.1
(16.8)
28.3
(15.2)
29.1
(16.9)
30.7 (5.6) 14.3 (3.6) 22.3 (1.9) 29.8 (2.7) 50.0
(19.2)
PFNA plasma
concentration (ng/mL)
0.7 (0.4) 0.8 (0.4) 0.7 (0.3) 0.7 (0.4) 0.7 (0.4) 0.7 (0.5) 0.8 (0.4) 0.5 (0.3) 0.6 (0.2) 0.8 (0.3) 1.0 (0.5)
Infant characteristics
Female (%) 48 48 45 47 48 48 47 48 48 49 46
BW/GA z-score 0.19 (0.96) 0.22
(0.94)
0.02
(1.08)
0.36
(0.92)
0.24
(0.96)
0.12
(0.97)
0.03
(0.98)
0.30
(0.98)
0.18
(0.98)
0.17
(0.95)
0.10
(0.94)
Birth weight (g) 3474 (591) 3484
(585)
3403
(626)
3560
(571)
3519
(532)
3424
(644)
3391
(597)
3562
(544)
3457
(652)
3477
(544)
3398
(609)
Gestational age
(weeks)
39.4 (1.9) 39.4 (2.0) 39.5 (1.8) 39.5 (1.9) 39.5 (1.6) 39.4 (2.2) 39.4 (2.0) 39.6 (1.5) 39.4 (2.3) 39.5 (1.7) 39.2 (2.2)
Abbreviations BMI Body mass index, BW/GA birth weight-for-gestational age, PFOS perfluorooctane sulfonate, PFNA perfluorononanoate, Q1 to 4 Quartiles 1 to 4
Missing in overall cohort: 12 pre-pregnancy BMI, 16 education & race/ethnicity
aFirst trimester black carbon quartile ranges: Q1 (0.13–0.56 μg/m3); Q2 (0.57–0.75 μg/m3); Q3 (0.76–0.92 μg/m3); and Q4 (0.93–1.71 μg/m3)
bPFOS plasma concentration quartile ranges: Q1 [<limit of detection (0.1)-18.8 ng/mL]; Q2 (18.9–25.6 ng/mL); Q3 (25.7–34.9 ng/mL); and Q4 (35.0–185.0 ng/mL)
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To aid in interpretability, we used the best-fit model
to calculate predicted BW/GA z-scores for extreme
exposure scenarios. As shown in Fig. 1, infants of
mothers with low levels of all three exposures (10th
percentile of black carbon and PFOS, and non-
smokers) had a predicted BW/GA z-score of 0.59
(95% CI: 0.49, 0.70) versus 0.31 (95% CI: 0.12, 0.49)
for infants of mothers with high levels of all expo-
sures (90th percentile of black carbon and PFOS, and
smokers), corresponding to an estimated birth weight
difference of 124 g for a white infant born at term
[29]. Infants with mixtures of some high and some
low exposures had BW/GA z-scores between 0.31 and
0.59 (Fig. 1).
In secondary analyses, infants of mothers who smoked
throughout pregnancy (continued smokers) had lower
BW/GA z-scores [− 0.40 (95% CI: -0.63, − 0.18)] com-
pared to infants of mothers who were non-smokers,
former smokers, or early pregnancy smokers, in the
best-fit main effects additive model (data not shown).
Maternal plasma concentration of PFNA was more
strongly associated with lower BW/GA z-score as com-
pared to PFOS [− 0.05 (95% CI: -0.10, − 0.01) per IQR
increment in PFNA versus − 0.03 (95% CI: -0.07, 0.02)
per IQR increment in PFOS in the covariate-adjusted
single-pollutant model]. The best-fit, multi-pollutant
model included positive two-way interactions between
PFNA plasma concentration and both prenatal smoking
and black carbon exposure (Additional file 1: Table S2).
Thus, the BW/GA z-score for infants of mothers with
high PFNA concentration and exposed to high black car-
bon or with high PFNA concentration and exposed to
maternal smoking, was not as low as expected based on
the individual associations of each of the pollutants with
fetal growth. For example, in the extreme exposure sce-
narios, infants of non-smoking mothers with low black
carbon and high PFNA concentration had a predicted
BW/GA z-score of 0.41 (95% CI: 0.27, 0.55) and infants
of non-smoking mothers with high black carbon and
low PFNA concentration had a predicted BW/GA z-
Table 2 Covariate-adjusted associationsa of prenatal smoking, first trimester residential black carbon, and prenatal perfluorooctane
sulfonate (PFOS) plasma concentration and their interactions with birth weight-for-gestational age (BW/GA) z-score
Smoking*BC Smoking*PFOS BC*PFOS LRT χ2 p-valueb
Change in BW/GA
z-score (95% CI)
Interaction β
(95% CI)
Single-pollutant exposure models
Prenatal smoking (Y/N) −0.09 (−0.24, 0.05)
First trimester black carbon (per IQR)b − 0.08 (− 0.15, − 0.01)
Prenatal PFOS plasma concentration
(per IQR)b
− 0.03 (− 0.07, 0.02)
Multi-pollutant exposure models
Main effects (Additive model) Smoking: −0.09 (− 0.23, 0.06) Reference
BC: −0.08 (− 0.15, − 0.01)
PFOS: −0.03 (− 0.08, 0.02)
Main effects + Smoking*BC Smoking: 0.04 (−0.39, 0.47) −0.06 (− 0.24, 0.13) 0.53
BC: −0.07 (− 0.15, 0.00)
PFOS: −0.03 (− 0.08, 0.02)
Main effects + Smoking*PFOS Smoking: −0.25 (− 0.57, 0.06) 0.09 (− 0.06, 0.24) 0.24
BC: −0.08 (− 0.15, − 0.01)
PFOS: −0.04 (− 0.09, 0.01)
Main effects + BC*PFOS Smoking: −0.08 (− 0.22, 0.06) 0.05 (−0.00, 0.11) 0.07 c
BC: −0.18 (− 0.31, − 0.05)
PFOS: − 0.14 (− 0.27, − 0.01)
Abbreviations χ2 chi-square, BC black carbon, BW/GA birth weight-for-gestational age, CI confidence interval, IQR interquartile range, LRT likelihood ratio test, PFOS
perfluorooctane sulfonate
Estimates with 95% confidence intervals that do not cross the null are bolded. Likelihood ratio test (LRT) chi-square (χ2) p-value < 0.05 indicates that the more
complex model is a better fit than the reference model
aAdjusted for maternal age, race/ethnicity, education, pre-pregnancy body mass index, and parity. The first trimester black carbon single-pollutant exposure model
was additionally adjusted for season and date of birth, and these covariates were included in all multi-pollutant exposure models
bInterquartile range increments: 0.36 μg/m3 for first trimester black carbon and 16.1 ng/mL for prenatal PFOS plasma concentration
cWhen we subsequently compared models with multiple two-way interactions and the three-way interaction to the best-fit model (main effects additive model),
all p-values were > 0.05
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score of 0.43 (95% CI: 0.29, 0.58), but infants of non-
smoking mothers with both high black carbon and high
PFNA concentration had a predicted BW/GA z-score of
0.39 (95% CI: 0.25, 0.53) (Additional file 1: Figure S1).
Discussion
In our analysis of a large, prospective cohort of
mother-infant pairs, we support previously reported
findings of lower birth size with higher prenatal ma-
ternal exposure to smoking, black carbon, and PFOS
in early pregnancy. We additionally found that simul-
taneous exposure to these compounds had an additive
rather than interactive effect on fetal growth. How-
ever, infants prenatally exposed to PFNA and either
maternal smoking or black carbon had a higher birth
size than expected based on the individual associa-
tions with fetal growth.
Associations between higher prenatal exposures to
maternal smoking, air pollution, and PFASs with
lower birth size have been previously reported in the
Project Viva cohort [3–5] and others [6–10]. In the
analytic cohort of the present study, while all three
exposures were associated with lower BW/GA, confi-
dence intervals crossed the null for early pregnancy
smoking and PFOS exposure. Other cohorts have
shown that maternal smoking in mid to late but not
early pregnancy leads to decrements in fetal growth
[6, 7, 35], on the order of 175–200 g lower birth
weight [6]. Consistent with this, in the Project Viva
cohort, prenatal smoking was most strongly associated
with low fetal growth for women who smoked
throughout pregnancy (versus those who did not),
corresponding to a decrement of 170 g in birth
weight for a full term white infant.
An association between higher prenatal air pollution
and lower birth weight has been shown in numerous
previous studies (e.g., [36–38]), with a pooled-effect of
23.4 g (95% CI: -45.5, − 1.4) lower birth weight per
10 μg/m3 of ambient PM2.5 (of which black carbon is a
component) in a recent meta-analysis [8]. For compari-
son, in the present analysis, we estimated a 36 g decre-
ment in birth weight (for a white term infant at the 50th
percentile of BW/GA z-score) for each IQR increment
in first trimester black carbon exposure.
PFASs may reduce fetal growth via activation of PPAR
or through structural similarity to free fatty acids which
may modulate lipid and glucose homeostasis [20], impair
placental transfer of lipids and glucose, and thereby lead
to oxidative stress [39]. A meta-analysis of nine studies
found a 19 g (95% CI: -30, − 8) lower birth weight for
each ng/mL increment in cord serum or maternal
plasma PFOA concentration [10]. This translates to a
49 g lower birth weight for each IQR increment of
PFOA using the IQR from U.S. females in NHANES
during 1999–2000 [40]. The present study found more
modest associations with PFOS and PFNA. For a white
term infant in the 50th percentile of BW/GA z-score, we
estimated a 10 g decrement in birth weight for each IQR
increment in maternal PFOS plasma concentration, al-
though confidence intervals included the null. We
Fig. 1 Predicted birth weight-for-gestational age z-scores for different scenarios of prenatal smoking, first trimester residential black carbon, and
prenatal perfluorooctane sulfonate (PFOS) plasma concentration. Error bars represent 95% confidence intervals. Estimates are based on a model
adjusted for maternal age, race/ethnicity, education, pre-pregnancy body mass index, parity, season of birth, and date of birth; are for a “typical”
(average) Project Viva participant: 31.8 years old, a college graduate, white, multiparous, and had a pre-pregnancy BMI of 25.0 kg/m2; and are for a
white full-term (40 weeks) offspring [29].
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estimated a larger, 19 g decrement in birth weight for
each IQR increment in maternal PFNA plasma
concentration.
The present study adds to the existing literature by
examining the extent to which early pregnancy exposure
to maternal smoking, black carbon, and select PFASs
interact to alter fetal growth. We found that while PFOS
did not modify the relationships of maternal smoking or
black carbon with fetal growth, PFNA attenuated the as-
sociations of smoking and black carbon on lower BW/
GA. This finding raises the possibility that PFNA may
act antagonistically on similar biological pathways as
maternal smoking and black carbon. For example, pla-
cental inflammation as a result of air pollution exposure
during pregnancy may lead to impaired nutrient ex-
change to the fetus and lower fetal growth [12]. PFAS
may counter pollution-induced placental inflammation
by inhibiting inflammatory gene expression via activa-
tion of PPAR [18, 19], thus leading to a higher
birth weight than otherwise expected from the concur-
rent exposures. Consistent with our finding of an inter-
action with PFNA but not PFOS, in mouse and human
models, PFNA activated PPAR-alpha at lower doses and
with higher potency than shorter chain carboxylates,
such as PFOA, or sulfonates, like PFOS [41]. Neverthe-
less, our finding requires replication in other cohorts.
We found that although maternal smoking and black
carbon independently lowered fetal growth, they did not
act synergistically. The prior literature on the association
between traffic pollution and birth outcomes for woman
prenatally exposed versus not exposed to cigarette
smoke is conflicting and limited. Specifically, in a study
of over 200,000 Canadian births, maternal smoking at-
tenuated the association between air pollution exposure
and low birth weight [42], whereas a study of over
600,000 U.S. births found the association between high
prenatal traffic-related carbon monoxide exposure and
low birth weight to be larger among smoking versus
non-smoking mothers [43]. In a U.S. urban cohort of
over 200 non-smoking pregnant women, passive smoke
exposure and a blood marker of ambient air pollution
(benzo[a]pyrene-DNA adducts) synergistically lowered
birth weight, although there were not independent asso-
ciations between either exposure with birth weight [44].
Even when we considered maternal smoking throughout
pregnancy, which was more strongly associated with low
fetal growth than early pregnancy smoking in the Project
Viva cohort, we observed no interaction with black car-
bon on fetal growth. Although cigarette smoking impairs
maternal immune function [45] and induces fetal hyp-
oxia [13], which could potentially cause a fetus to be
more vulnerable to the effects of other pollutants like
black carbon, mothers in our cohort may not have been
heavy enough smokers to significantly weaken responses
to these other toxicants. Alternatively, the fact that
cigarette smoke and black carbon exposure impact fetal
growth through similar mechanisms of action may ex-
plain their additive rather than synergistic or antagonis-
tic mechanism of action. Furthermore, we may not have
had the power to detect an interaction between maternal
smoking and black carbon exposure on fetal growth be-
cause only a small proportion of the cohort smoked dur-
ing pregnancy and variability of ambient black carbon
concentrations in the Boston area is relatively low.
Power to detect an interaction between these two expo-
sures may have been further limited because of exposure
misclassification. Social desirability bias may have intro-
duced some misclassification into our questionnaire
measure of maternal smoking, and we did not have data
on work location or time at home which could have im-
proved the accuracy of black carbon exposure estimates
[46]. In contrast, PFAS exposure was less likely to be
misclassified, as these compounds have long half-lives,
and we measured concentrations in plasma.
Although our current analysis uniquely studied how
maternal smoking, black carbon, and PFASs may inter-
act to influence birth size, prior studies have focused on
how mixtures of other pollutants may impact birth
weight. One study of about 1000 European mother-
infant pairs observed a stronger negative cross-sectional
association between cord blood dioxin-like activity and
birth weight among infants of women who smoked dur-
ing pregnancy versus non-smokers, but the interaction
was not significant [47]. Another study of over 1000
mother-infant pairs from Greenland, Poland, and
Ukraine observed greater birth weight reductions for in-
fants of smokers concomitantly prenatally exposed to
PFOA and di(2-ethylhexyl) phthalate (DEHP) versus
non-smokers exposed to these two chemicals [48]. Add-
itionally, a study of about 250 Flemish mother-infant
pairs found a larger decrement in birth weight in infants
simultaneously exposed to arsenic, PFOA, lead, cad-
mium, and DEHP as compared to individual exposures,
although they did not test for interactions between com-
pounds [49].
The multi-pollutant model approach allows for evalu-
ation of joint effects and is generally expected to
minimize co-exposure confounding [50]. However, as is
the case with single-pollutant models, misspecification
due to adjustment for irrelevant or collider variables, or
lack of adjustment for confounder variables could lead
to bias [51, 52]. Although collinearity between exposures
in a multi-pollutant model could decrease precision of
effect estimates [50], this was not a limitation of the
present analysis, as the exposures we studied were not
tightly correlated.
Generalizability is a limitation of our cohort, as partic-
ipants are primarily of moderately high socioeconomic
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status and all resided in Massachusetts at enrollment. In
addition, although we limited our primary analysis to
early pregnancy exposures for which we have the most
robust data, timing of exposure could alter independent
and combined effects of these pollutants on fetal
growth. Also, to target our analysis and limit multiple
comparisons, we focused on one air pollutant (black
carbon) and one PFAS (PFOS) in our primary analyses,
although pregnant women are exposed to several types
of air pollutants and PFAS concurrently. Our observa-
tion that PFNA had stronger independent and com-
bined effects on fetal growth than PFOS suggests that
specific PFASs may act differently. However, PFNA
plasma concentrations have a relatively narrow range in
our cohort, and thus we cannot generalize our findings
to women with higher PFNA concentrations.
Strengths of our study include use of a large prospect-
ive cohort with measurements of multiple prenatal en-
vironmental exposures known to influence fetal growth.
Additionally, most environmental epidemiological stud-
ies examine the effect of a single pollutant on health
outcomes, despite the fact that individuals are exposed
to multiple pollutants concurrently [21]. We present an
approach, of examining multi-pollutant models with
two-way and three-way interactions, to investigate health
effects related to joint exposure to multiple toxicants.
Conclusion
We observed that concurrent early pregnancy exposures
to maternal smoking, residential black carbon, and PFOS
were associated with additive reductions in fetal growth,
while exposure to PFNA attenuated the associations of
smoking and black carbon exposure on low birth size, in
a Boston-area cohort. Because a developing fetus is ex-
posed to mixtures of chemicals, it is critical to continue
to evaluate the role of multiple pollutant exposures in
future studies. Further investigation of the effect of mix-
tures of in utero exposures on health outcomes may pro-
vide insight into potential biological pathways of action.
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